Response gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3

BACKGROUND: Response gene to complement-32 (RGC-32) is comprehensively expressed in many kinds of tissues and has been reported to be expressed abnormally in different kinds of human tumors. However, the role of RGC-32 in cancer remains controversial and no reports have described the effect of RGC-3...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Liang, Qin, Hua, Li, Pei-Yuan, Xu, Sheng-Nan, Pang, Hui-Fang, Zhao, Hui-Zhen, Li, De-Min, Zhao, Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337240/
https://www.ncbi.nlm.nih.gov/pubmed/22458379
http://dx.doi.org/10.1186/1756-9966-31-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337240/
https://www.ncbi.nlm.nih.gov/pubmed/22458379
http://dx.doi.org/10.1186/1756-9966-31-29

Ejemplares similares